Recent

% | $
Quotes you view appear here for quick access.

Neurocrine Biosciences Inc. Message Board

  • yboth yboth Jul 30, 1999 12:44 PM Flag

    News release

    Tell me if I am wrong, but this news release is
    just informing us that they are going into Phase II
    for this insomnia drug. Which I assume WAS expected.
    If that is true it should not create a stir, YET.
    When it passes, which is an unknown at this time, then
    the stock will rise.

    I do not expect any
    change due to this news release.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • SAN DIEGO, Calif., July 30 (dbusiness) �
      Neurocrine Biosciences Inc. will be initiating a new phase
      of testing for its insomnia product.

      The
      phase II clinical study will assess the safety of the
      product in a laboratory setting among approximately 228
      patients. Phase I testing found the product to be �safe and
      well tolerated� among healthy volunteers, according to
      the company.


      Jamie

 
NBIX
36.04+0.67(+1.89%)Feb 12 4:00 PMEST